Pulse Biosciences Inc (PLSE) Q3 2026 Earnings Call Highlights: NanoPulse AF Study Enrollment ...
Pulse Biosciences Inc (PLSE) wrapped up enrollment in its NanoPulse AF pivotal IDE study three months early while reporting a wider GAAP net loss of $23.1 million and roughly two years of cash runway. Related Stocks: PLSE ,